Feed PRFX
PR
PainReform Ltd.
PRFX · NASDAQ
$1.03 -3.74% (-$0.04)
1M -12.71%
Market Cap $96.6K
P/E Ratio -
Div. Yield -
ROE 79.59%
Bulios Fair Price
$1.33
29.1% upside
Preț actual
$1.03
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile PRFX sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Valuation
100 /100
Cheap P/B 0.01x
EV/EBITDA N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 8.14%
Rev. growth 41.75%
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 79.59%
ROA 36.61%
Asset turnover 0.00x
Debt
93 /100
Low Current ratio 1.59x
Debt/Equity 0.01x
Net debt/EBITDA N/A
Stability
49 /100
Moderate EPS volatility 45.18%
Profitable years 0
Beta 1.05x
Întreabă StockBot despre PRFX
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Efraim Cohen-Arazi
Employees
7
Headquarters
Tel Aviv